Meeting
2011 ASCO Annual Meeting
Pilot study of cisplatin, 5-fluorouracil, and a taxane (TPF) for advanced squamous cell carcinoma (SCC) of the penis.
Authors
R. Salvioni
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
R. Salvioni , N. Nicolai , L. Piva , M. Catanzaro , T. Torelli , D. Biasoni , S. Stagni , A. Milani , A. Necchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer
Track
Genitourinary Cancer
Sub Track
Other GU Cancer
Citation
J Clin Oncol 29: 2011 (suppl; abstr 4639)
Abstract #
4639
Poster Bd #
9G
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase II prospective trial of induction chemotherapy for advanced sinonasal squamous cell or poorly differentiated carcinoma.
First Author: Kevin J. Contrera
Poster
2016 Gastrointestinal Cancers Symposium
Systemic therapy for advanced anorectal squamous cell carcinomas: A single institutional experience.
First Author: Patrick McKay Boland
Poster
2014 Genitourinary Cancers Symposium
Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): Results of a single high-volume center.
First Author: Patrizia Giannatempo
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Recurrence-free survival as a surrogate for overall survival in esophageal squamous cell carcinoma: Nationwide real-world data from Japan.
First Author: Jun Okui